BG00011 was shown to suppress TGF-β activation in IPF patients, as evidenced by a reduction of p-SMAD2 signalling and TGF-β dependent gene expression in the BAL cells of patients. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.